Technology | August 13, 2007

Ethicon Endo-Surgery Introduces New MR Breast Biopsy Device

The newly launched Universal Mammotome MR Biopsy System from Ethicon Endo-Surgery is compatible with a wider range of breast coils and magnets and can work with most grid/cube location systems, the most common method of MR lesion targeting.
The Mammotome MR Universal Targeting Set is designed for fast and easy set up, can be used with most grid localization systems and its imageable aperture allows physicians to visually verify the placement of the probe relative to the targeted lesions.
The Mammotome MR Universal’s depth locking system — the “Z-lock” provides stability and maintains consistent depth during sampling, the company reports. Multiple needle lengths and probe sizes allow for maximum breast access and rapid tissue acquisition based on individual patient/lesion characteristics. Anesthesia can be administered throughout the procedure using its targeting set and vacuum tubing.
A Mammotome MR Biopsy System procedure involves the single insertion of a needle equipped with a vacuum device into an incision about the size of a match head, says the company. Under MRI guidance, the device gently vacuums, cuts and partially or completely removes suspicious breast tissue for evaluation. The outpatient procedure can be performed in an MRI suite and typically takes an average of 30 minutes.

Related Content

Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Sponsored Content | Videos | Women's Health | November 16, 2016
The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate...
stereotactic breast imaging

This image shows a 52-year-old patient with benign calcifications in her pre-stereotactic breast biopsy screening.

Feature | Breast Biopsy Systems | November 01, 2016 | By Laura Shepardson, M.D.
Recently, I was invited to participate in a...
Hologic, FDA approval, launch, Affirm prone biopsy system, breast cancer, women's health
Technology | Breast Biopsy Systems | April 21, 2016
Hologic Inc. announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm prone...

Breast surgeon Michael Cross, M.D., has done clinical research on the DotMed BioZorb surgical marker. (Photo courtesy of DotMed)

Feature | Women's Health | November 11, 2015
Breast cancer research conducted by two Fayetteville, Ark., medical groups highlights their success in pioneering use
Hologic, RSNA 2015, breast tomosynthesis, breast biopsy systems

I-View contrast enhanced 2-D mammography image courtesy of Hologic

Technology | Breast Imaging | October 02, 2015
October 2, 2015 — At the Radiological Society of North America’s (RSNA) 2015 annual meeting, Hologic will emphasize i
hologic mammography Selin
News | Breast Imaging | October 01, 2015
October 1, 2015 — The recent KLAS Research women’s imaging report, Women's Imaging 2015.
Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014
Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance...
News | November 12, 2014
GTCR, a private equity firm, announced Devicor Medical Products has signed an agreement to be acquired by Danaher Corp...
News | November 11, 2014
Seno Medical Instruments Inc. announced that the use of the Seno Imagio breast imaging system and the associated...
Overlay Init